General Practice · Bayamon, PR
NPI
1265633069
Since 2007
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Calle Central Juanita (Final)
Bayamon, PR, 00960
Phone (787) 778-5757
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.2M
3,301 prescriptions
Company payments, 2025
$554
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Celestino Flores prescribed most often to Medicare patients was Omega-3 Acid Ethyl Esters, with 429 prescriptions and refills. In total Celestino Flores wrote 3,301 Medicare prescriptions that cost $4.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Omega-3 Acid Ethyl Esters Generic | 429 | 474 | 67 | $9,598 |
| Rosuvastatin Calcium Generic | 282 | 343 | 47 | $1,946 |
| Descovy Emtricitabine/Tenofov Alafenam | 206 | 212 | 28 | $467K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 175 | 187 | 20 | $879K |
| Delstrigo Doravirine/Lamivu/Tenofov Diso | 157 | 157 | 17 | $416K |
| Tivicay Dolutegravir Sodium | 148 | 148 | 19 | $335K |
| Dovato Dolutegravir Sodium/Lamivudine | 113 | 113 | 12 | $336K |
| Isentress Hd Raltegravir Potassium | 111 | 113 | 14 | $225K |
| Synthroid Levothyroxine Sodium | 86 | 90 | 13 | $4,417 |
| Prezcobix Darunavir/Cobicistat | 82 | 86 | 12 | $212K |
| Gabapentin Generic | 78 | 82 | Under 11 | $740 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 73 | 79 | Under 11 | $287K |
| Atorvastatin Calcium Generic | 72 | 80 | 11 | $375 |
| Omeprazole Generic | 67 | 67 | Under 11 | $266 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 65 | 65 | Under 11 | $243K |
Brand drugs: 1,515 claims; generic drugs: 1,768 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Celestino Flores $554 ($554 in general payments such as food, travel and fees) from 4 companies. The largest payer was Gilead Sciences, Inc. with $343.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.